![Adobe Stock](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMjQvMDIvMDkvY29sb19jYW5uYWJpbm9pZHMuanBn.ccApnQVUpA0.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
Adobe Stock
Colorado cannabis regulators scheduled a pair of meetings for March 1 and March 8 to seek input from industry stakeholders on a report revolving around product safety profiles and potential for intoxication that they must submit to state lawmakers.
The state’s Marijuana Enforcement Division (MED) has also contracted a research team at the University of Colorado—Boulder to help develop this report, which will analyze the feasibility of establishing a standing committee to evaluate cannabinoids and cannabis- and hemp-derived products.
The report is mandated by legislation Democratic Gov. Jared Polis signed into law last year “concerning the regulation of compounds that are related to cannabinoids.”
Specifically, the law creates a new framework for the Colorado Department of Revenue, which oversees MED, to regulate and register hemp products as well as for MED to regulate intoxicating products “or potentially intoxicating compounds” that are or may be cannabinoids.
Under the legislation, the state must classify hemp- and cannabis-derived compounds and cannabinoids into one of three categories: nonintoxicating cannabinoids; potentially intoxicating cannabinoids; and intoxicating cannabinoids.
As outlined in the act, the MED’s regulatory authority includes:
- The power to promulgate rules authorizing or prohibiting chemical modification, conversion, or synthetic derivation to create certain types of intoxicating cannabinoids;
- Classifying and reclassifying cannabinoids as intoxicating, potentially intoxicating, or nonintoxicating;
- Labeling and advertising requirements;
- Production and testing requirements;
- Inspection, record-keeping, surveillance, and inventory tracking requirements;
- Prohibiting the export of a safe harbor hemp product that is a synthetic cannabinoid or that is being exported to a state where it is illegal; and
- Issuing a cease-and-desist order or clean-up order.
While nonintoxicating cannabinoids may be produced, distributed or sold as a hemp product—as federally legalized under the 2018 Farm Bill—products containing potentially intoxicating compounds or intoxicating cannabinoids can only be produced, distributed or sold by a MED licensee, according to the legislation.
The legislation also requires the executive director of the Revenue Department to submit the aforementioned report to the General Assembly.
The two meetings seeking public input from industry stakeholders will be hybrid with both in-person and virtual options. Meeting agendas, which will include targeted questions for consideration, will be made public one week prior to each meeting.
Below are details for each meeting:
First Meeting: March 1, 2024 (2-4 p.m.)
In-person:
- Red Rocks Conference Room
- 1700 Cole Blvd., Ste. 300
- Lakewood, CO 80401
Zoom Option:
- https://us02web.zoom.us/j/88496438113
- Meeting ID: 884 9643 8113
- Call-in Number: +17193594580
Second Meeting: March 8, 2024 (2-4 p.m.)
In-person:
- Red Rocks Conference Room
- 1700 Cole Blvd., Ste. 300
- Lakewood, CO 80401
Zoom Option:
- https://us02web.zoom.us/j/88496438113
- Meeting ID: 884 9643 8113
- Call-in Number: +17193594580
Latest from Cannabis Business Times
- USC Athletics, Cookies Announce Trailblazing CBD Partnership for College Football, Basketball Sponsorship
- Trulieve Set to Open Medical Cannabis Dispensary in Clearwater
- Kentucky’s Medical Cannabis Program Attracts 5K License Applicants
- AYR Wellness Awarded Virginia’s HSA I Vertical Cannabis License
- Navigating the Green Line: How to Balance Selling and Profitability in Cannabis Retail
- DCC’s ‘Inadequate Oversight’ of $100M Undermined California Licensing Program for Cannabis Growers
- High Tide to Open Canna Cabana Store in Lucan, Ontario
- Whitney Economics Reduces 2030 Hemp Fiber and Grain Acreage Forecast by 4.5 Million Acres